Pharmacogenetics of clozapine remission

Project Details

This project is aimed at the discovery of genomic, transcriptomic, and/or proteomic markers for clozapine mediated symptom remission with particular focus on the NRG1-ErbB pathway. In addition, we are exposing healthy peripheral blood mononuclear cells to clozapine for 24 hours and seven days to estimate acute and chronic effects of clozapine on NRG1-ErbB pathway gene and protein expression.

Funding

  • CRC for Mental Health

Research Group

Melbourne Neuropsychiatry Centre Research



Faculty Research Themes

Neuroscience

School Research Themes

Neuroscience and Psychiatry



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Psychiatry